Acurx Pharmaceuticals published a study showing that novel oral PolC inhibitors effectively reduce MRSA infections in mice while preserving gut microbiome diversity and metabolic function, unlike the commonly used antibiotic linezolid which disrupts gut bacteria. These inhibitors specifically maintain healthy anaerobic gut bacteria and metabolic pathways, highlighting their potential as microbiome-friendly antibiotics. Acurx's lead candidate, ibezapolstat, is advancing toward Phase 3 trials for C. difficile infection and has FDA Fast-Track and QIDP designations. The findings support further development of these narrow-spectrum antibiotics targeting serious Gram-positive infections with reduced risk of gut dysbiosis.
Acurx Pharmaceuticals' recent publication on its DNA pol IIIC inhibitor pipeline provides context for readers interested in health-sector developments. For readers following the health sector, here is Pluang's market snapshot as of Oct 21, 2026 18:11 WIB: Among 150 priced health-sector US stocks tradable on Pluang, 71 rose and 67 fell today. Notable movers include TNGX at USD 26.20 with a 3.76% increase and a typical hold time of 6 days, BAX at USD 25.30 up 3.22% with balanced Pluang order activity and a 73-day hold time, and NUVB at USD 4.91 gaining 2.94% with a 12-day typical hold time.
The BBB National Programs’ National Advertising Division reviewed Royal Caribbean Group's advertising related to gratuities and found the company's recent modifications to be supported. Royal Caribbean clarified in its booking process that gratuities...
Deutsche Bank increased its price target for Kroger to $70 from $68, reflecting a potential 10.7% upside. Kroger announced strategic growth initiatives including a $5 billion customer-value investment and plans to open 110 new stores by 2029. The com...
Crown Castle is set to report its Q3 2026 earnings with Wall Street expecting a 5.9% revenue decline to about $1.01 billion, mainly due to drops in site rental and services revenue. However, some forecasts predict a 7.1% rise in earnings per share to...
PypeServer has released Cloud+ version 3.0, enabling HVAC contractors to manage both ductwork and piping fabrication on a single platform. This update allows seamless tracking from design through installation, integrating with existing design softwar...
Kevel secured $52 million in its largest funding round to date, boosting its AI-powered infrastructure for commerce media networks. The capital will accelerate product innovation, transparent AI decisioning, and global expansion, helping retailers an...
